BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20190101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200908
DTEND;VALUE=DATE:20200909
DTSTAMP:20260515T113630
CREATED:20200908T095405Z
LAST-MODIFIED:20200908T095405Z
UID:26947-1599523200-1599609599@www.pharmajournalist.com
SUMMARY:Glioblastoma Drug Development Summit
DESCRIPTION:After an exceptionally successful inaugural launch last year\, the 2nd Annual Glioblastoma Drug Development Summit returns this year in an exclusive virtual format. \nGBM Drug Development is the only devoted meeting for large pharma\, biotech and pioneering academics which guarantees to unite all stakeholders under a mutual and ambitious objective of accelerating the practical discovery\, translation\, and clinical development of safe\, effective and deliverable therapies to treat glioblastoma\, an extremely aggressive cancer with a huge medical unmet need. \n \nConfronting specific and applied drug development obstacles with inadequate successful treatments\, such as the knowledge of glioblastoma’s mechanisms of resistance and lack of penetration via the blood brain barrier\, the 2nd Glioblastoma Drug Development Summit will help neuro-oncologists\, neurosurgeons  and oncology professionals from biopharma effectively translate their drug candidates into human clinical trials\, whilst optimizing the clinical development process itself to evade further clinical failures. \n\nBrought direct to your home office with a jam-packed agenda and online virtual networking opportunities\, this exclusive virtual summit will delve into the common challenges with developing GBM therapies\, whilst striving to advance safe and effective therapeutic breakthroughs to patients in need. \n\nTo know more about Glioblastoma Drug Development Summit please click here.
URL:https://www.pharmajournalist.com/event/glioblastoma-drug-development-summit/
LOCATION:Online
ORGANIZER;CN="Hansonwade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR